Related Experiment Video
Updated: Aug 17, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Measles and measles immunity in children infected with human immunodeficiency virus
1Deparment of Pediatrics, New York University Medical Center, NY 10016.
Abstract:
The development of measles vaccination recommendations for immunodeficient children infected with human immunodeficiency virus requires assessment of disease risk and the risks and benefits of vaccination. Measles in 4 such children resulted in 3 severe pneumonias and 1 death despite previous immunization in 2. Antibody to measles as determined by enzyme-linked immunosorbent assay was present in 3 (12.5%) of 24 children studied retrospectively and developed in only 2 (25%) of 8 children immunized and followed up prospectively. The sera of 9 of 24 children had antibody when tested by sensitive hemagglutination inhibition. Measles developed in 2 of 6 children who had negative enzyme-linked immunosorbent assay results and positive hemagglutination inhibition results. No adverse consequences of measles immunization were detected. Although the immunogenicity of measles vaccine in children infected with human immunodeficiency virus was low and vaccine failure occurred, the apparent safety provides the rationale for immunization in the face of a potentially fatal disease. Since neither documented immunization nor low-level antibody guaranteed immunity to measles, we recommend passive postexposure immunoglobulin prophylaxis for all children infected with human immunodeficiency virus.
Insights
Measles vaccination in children with human immunodeficiency virus (HIV) showed low effectiveness but was safe. Post-exposure immunoglobulin is recommended due to vaccine failure risks.
Area of Science:
- Pediatrics
- Immunology
- Infectious Diseases
Background:
- Measles poses a severe risk to immunodeficient children, including those with human immunodeficiency virus (HIV).
- Previous measles immunization does not guarantee protection in HIV-infected children, as evidenced by severe cases and fatalities despite prior vaccination.
Purpose of the Study:
- To assess the risks and benefits of measles vaccination in children with HIV.
- To evaluate the immunogenicity and safety of measles vaccine in this vulnerable population.
Main Methods:
- Retrospective and prospective study of measles vaccination in HIV-infected children.
- Antibody levels measured by enzyme-linked immunosorbent assay (ELISA) and hemagglutination inhibition (HAI).
Main Results:
- Measles infection in 4 HIV-infected children led to severe pneumonia in 3 and 1 death, even with prior immunization.
- Low measles antibody levels were detected post-vaccination (25% in prospective group) and pre-vaccination (12.5% retrospectively).
- Vaccine failure occurred in children with negative ELISA but positive HAI results, indicating unreliable immunity.
Conclusions:
- Measles vaccination in HIV-infected children demonstrates low immunogenicity and vaccine failure.
- Despite low efficacy, the vaccine appears safe, supporting its use in the context of potentially fatal measles disease.
- Due to unreliable immunity from vaccination alone, passive post-exposure immunoglobulin prophylaxis is recommended for all HIV-infected children.
Related Concept Videos
Vaccinations
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Chickenpox
Cytomegalovirus Disease
Respiratory Syncytial Virus Disease

